Thirty-Day Periprosthetic Joint Infection After Hip and Knee Arthroplasty: Clinical Correlates and Microbiology in a Tertiary Referral Cohort
In a tertiary referral cohort of 975 hip and knee arthroplasties, revision surgery was identified as the strongest predictor of 30-day periprosthetic joint infection, which accounted for nearly 60% of first-year cases and showed a distinct microbiological profile with a higher prevalence of Gram-negative organisms compared to later infections.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a surgeon replaces a worn-out hip or knee with a metal and plastic joint, the goal is to restore movement and end pain. But sometimes, the body fights back in a way that is far more dangerous than the original arthritis: an infection takes hold around the new implant. This is called a periprosthetic joint infection. It is a serious complication that can force patients to undergo multiple surgeries, endure long courses of antibiotics, and face a decline in their ability to walk or function. Doctors know that catching these infections early is vital, but they have debated exactly when the risk is highest and which patients are most vulnerable. Is the danger immediate, or does it creep up slowly over months? Does the type of surgery matter, or is the patient's underlying health the deciding factor? Answering these questions helps hospitals decide how closely to watch patients after they leave the operating room.
A team of researchers at a major medical center in Mexico City set out to answer these questions by looking at nearly a thousand hip and knee replacement surgeries performed over fifteen years. They focused specifically on infections that appeared within the first thirty days after the operation. By examining the medical records of 735 adults who underwent these procedures, the team wanted to see if they could spot clear patterns in who got sick and what kind of germs were causing the trouble. Their work was not about inventing new drugs or surgical techniques, but rather about sorting through real-world data to understand the timing and nature of these early infections. They looked at factors like the patient's age, whether they had diabetes or rheumatic diseases like arthritis, if they were taking steroid medications, and whether the surgery was a first-time replacement or a revision to fix a previous implant.
The researchers found that the risk of infection is heavily concentrated in the very first month after surgery. Of all the infections that occurred within the first year, nearly sixty percent were diagnosed within the first thirty days. In fact, more than ninety-five percent of all first-year infections were identified within the first three months. This suggests that the period immediately following the operation is the most critical window for detection. The study also revealed that the type of surgery made a significant difference. Patients who underwent a revision surgery—where a doctor replaces an existing implant—were much more likely to develop an infection in the first month compared to those having their first-ever joint replacement. The data showed that revision patients faced roughly three times the odds of an early infection compared to primary patients. This finding held true even when the researchers adjusted for other factors like age, body weight, and the presence of other medical conditions.
While the link to revision surgery was strong and consistent, the picture was less clear for patients with rheumatic diseases. The study found that people with conditions like rheumatoid arthritis or lupus did appear to have a higher rate of early infections, but the statistical evidence was not as solid as it was for the revision group. Depending on how the researchers analyzed the data, the connection to rheumatic disease sometimes appeared strong and sometimes faded into uncertainty. Similarly, while many patients in the study were taking corticosteroids, the data did not show a clear, direct link between taking these drugs and getting an infection within the first month. The researchers noted that their records did not contain enough detail about the specific doses or timing of these medications to draw a firm conclusion.
The team also looked at the microscopic culprits behind these infections. They found that the types of bacteria causing early infections were different from those causing infections that appeared later in the year. In the first thirty days, a much larger share of the infections were caused by gram-negative bacteria, a group that includes organisms like Pseudomonas and E. coli. In contrast, infections diagnosed later in the year were more often caused by gram-positive bacteria, such as Staphylococcus aureus. This shift in the type of germ suggests that the source of the infection might change over time, perhaps starting with bacteria introduced during the surgery itself and later involving different organisms that enter the body through other means. However, the researchers cautioned that this observation was based on a limited number of cases and would need further study to confirm.
The study was conducted at a specialized hospital that treats many complex cases, including patients with multiple health problems and those requiring difficult revision surgeries. Because of this, the rates of infection observed here are higher than what might be seen in a typical community hospital where patients are generally healthier and having their first joint replacement. The researchers emphasized that their findings describe the specific challenges of their patient population rather than a universal rule for all hospitals. Despite these limitations, the work provides a clear map of the early postoperative period. It confirms that the first month is a time of intense vulnerability, especially for those undergoing complex revision surgeries. The findings suggest that hospitals should focus their most intense monitoring and care during this initial window, while still maintaining vigilance throughout the first year, as a small number of infections do appear later. The study does not offer a new cure, but it offers a clearer understanding of when and where to look, helping doctors protect patients during the most dangerous phase of their recovery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.